114450 — Green LifeScience Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩35bn
- KR₩28bn
- KR₩22bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 37,618 | 24,561 | 25,338 | 36,505 | 22,369 |
Cost of Revenue | |||||
Gross Profit | 3,032 | -74.6 | -2,270 | -1,356 | -2,310 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 37,027 | 26,470 | 29,986 | 40,463 | 39,107 |
Operating Profit | 591 | -1,909 | -4,648 | -3,958 | -16,738 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,340 | -871 | -3,418 | -2,860 | -16,358 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,196 | -1,059 | -3,136 | -3,526 | -16,358 |
Net Income Before Extraordinary Items | |||||
Net Income | 1,196 | -1,059 | -3,136 | -3,526 | -16,358 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,196 | -1,059 | -3,136 | -3,526 | -16,358 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 59.3 | -53 | -157 | -176 | -214 |
Dividends per Share |